Abstract
Management of medication overuse headache (MOH) requires abrupt suspension of overused drugs either alone or in association with a detoxification protocol to prevent withdrawal. However, there is no consensus about which suspension strategy is the most effective. Moreover, reliable data about the possible mid-term effect of detoxification are not available. The objective of this study was to evaluate whether a bridge therapy consisting of a 5-day i.v. infusion of methylprednisolone and diazepam determines a significant reduction in headache frequency and drug assumption during the detoxification protocol (day 5) and in the first 3 months in patients with MOH. We conducted a retrospective non-randomized before-and-after study comparing patients with MOH undergoing a bridge therapy protocol (5-day infusion of methylprednisolone, diazepam) with those who refused the treatment and were only recommended to suspend overused painkillers. Both groups started a prophylactic treatment and were followed-up for 3 months. At day 5, 82% of our patients were headache-free; moreover, 48% of the patients did not take any painkiller during the 5-day treatment. Three months after, the intervention group showed a greater reduction of monthly headache days (9.4 vs 3.0) and drugs (19.7 vs 6.5), a greater rate of patients with a ≥ 50% reduction of monthly headaches (p = 0.019) and symptomatic drug consumption (p = 0.000), than the control group. The methylprednisolone and diazepam detoxification protocol reduced headache attacks and drug assumption immediately and in the first 3 months after the intervention, concurring to improve the effect of a new prophylactic therapy.
Similar content being viewed by others
References
Headache Classification Committee of the International Headache Society (IHS) (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33:629–808
Diener H-C, Holle D, Solbach K, Gaul C (2016) Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol 12:575–583
de Goffau MJ, Klaver ARE, Willemsen MG et al (2016) The effectiveness of treatments for patients with medication overuse headache; a systematic review and meta-analysis. J Pain. https://doi.org/10.1016/j.jpain.2016.12.005
Leppert W, Buss T (2012) The role of corticosteroids in the treatment of pain in cancer patients. Curr Pain Headache Rep 16:307–313
Neeb L, Hellen P, Boehnke C et al (2011) IL-1β stimulates COX-2 dependent PGE2 synthesis and CGRP release in rat trigeminal ganglia cells. PLoS One 6:e17360–e17310
Antonova M, Wienecke T, Olesen J, Ashina M (2013) Prostaglandins in migraine: update. Curr Opin Neurol 26:269–275
Bøe MG, Mygland Å, Salvesen R (2007) Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology 69:26–31
Pageler L, Katsarava Z, Diener H-C, Limmroth V (2008) Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia 28:152–156
Rabe K, Pageler L, Gaul C et al (2013) Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study. Cephalalgia 33:202–207
Taghdiri F, Togha M, Razeghi Jahromi S, Paknejad SMH (2015) Celecoxib vs prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind clinical trial. Headache 55:128–135
Cevoli S, Giannini G, Favoni V, Terlizzi R, Sancisi E, Nicodemo M, Zanigni S, Bacchi Reggiani ML, Pierangeli G, Cortelli P (2017) Treatment of withdrawal headache in patients with medication overuse headache: a pilot study. J Headache Pain 18(1):56
Trucco M, Meineri P, Ruiz L, on behalf of the “Gruppo Neurologico Ospedaliero Interregionale per lo Studio delle Cefalee” (Neurological Hospital Interregional Group for the Study of Headache) (2005) Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache. J Headache Pain 6:334–337
Funding
The study had no external funding source.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics or institutional review board approval
The ethics committee of Campus Bio-Medico University was informed about this retrospective study.
Rights and permissions
About this article
Cite this article
Paolucci, M., Altamura, C., Brunelli, N. et al. Methylprednisolone plus diazepam i.v. as bridge therapy for medication overuse headache. Neurol Sci 38, 2025–2029 (2017). https://doi.org/10.1007/s10072-017-3098-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-017-3098-z